Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, R Barr G, Chang BP, Chau KH, Choi JJ, Gavin N et al..  2020.  Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.. BMJ. 369:m1996.

Choi JJ, Wehmeyer GT, Li HA, Alshak MN, Nahid M, Rajan M, Liu B, Schatoff EM, Elahjji R, Abdelghany Y et al..  2020.  D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.. Thromb Res. 196:318-321.

Goyal P, Ringel JBryan, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ et al..  2020.  Obesity and COVID-19 in New York City: A Retrospective Cohort Study.. Ann Intern Med. 173(10):855-858.

Goyal P, Requijo T, Siceloff B, Shen MJ, Creber RMasterson, Hilmer SN, Kronish IM, Lachs MS, Safford MM.  2020.  Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.. Drugs Aging. 37(2):125-135.

Goyal P, Kneifati-Hayek J, Archambault A, Mehta K, Levitan EB, Chen L, Diaz I, Hollenberg J, Hanlon JT, Lachs MS et al..  2020.  Reply: Toward Improved Understanding of Potential Harm in Heart Failure.. JACC Heart Fail. 8(3):247-248.

Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, Goyal P, Sepulveda JL, Zhang L, George G et al..  2020.  SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.. Cancer Cell. 38(5):661-671.e2.

Yum B, Archambault A, Levitan EB, Dharamdasani T, Kneifati-Hayek J, Hanlon JT, Diaz I, Maurer MS, Lachs MS, Safford MM et al..  2019.  Indications for β-Blocker Prescriptions in Heart Failure with Preserved Ejection Fraction.. J Am Geriatr Soc. 67(7):1461-1466.

Kennel PJ, Kneifati-Hayek J, Bryan J, Banerjee S, Sobol I, Lachs MS, Safford MM, Goyal P.  2019.  Prevalence and determinants of Hyperpolypharmacy in adults with heart failure: an observational study from the National Health and Nutrition Examination Survey (NHANES).. BMC Cardiovasc Disord. 19(1):76.

Salata BM, Sterling MR, Beecy AN, Ullal AV, Jones EC, Horn EM, Goyal P.  2018.  Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services.. Am J Cardiol. 121(9):1076-1080.

Krishnan U, Brejt JA, Schulman-Marcus J, Swaminathan RV, Feldman DN, S Wong C, Goyal P, Horn EM, Karas M, Sobol I et al..  2017.  Characteristics of hospitalizations for cardiogenic shock after acute myocardial infarction in the United States.. Int J Cardiol. 244:213-219.

Goyal P, Paul T, Almarzooq ZI, Peterson JC, Krishnan U, Swaminathan RV, Feldman DN, Wells MT, Karas MG, Sobol I et al..  2017.  Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction.. J Am Heart Assoc. 6(4)

Goyal P, Almarzooq ZI, Horn EM, Karas MG, Sobol I, Swaminathan RV, Feldman DN, Minutello RM, Singh HS, Bergman GW et al..  2016.  Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction.. Am J Med. 129(6):635.e15-26.

Schulman-Marcus J, Goyal P, Swaminathan RV, Feldman DN, Wong S-C, Singh HS, Minutello RM, Bergman G, Kim LK.  2016.  Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness.. Am J Cardiol. 117(9):1405-10.

Goyal P, Sterling MR, Beecy AN, Ruffino JT, Mehta SS, Jones EC, Lachs MS, Horn EM.  2016.  Patterns of scheduled follow-up appointments following hospitalization for heart failure: insights from an urban medical center in the United States.. Clin Interv Aging. 11:1325-1332.